Literature DB >> 2596866

Mitogenic activities for skin fibroblasts in the sera from untreated scleroderma patients at the early stage.

A Igarashi1, K Takehara, Y Soma, K Kikuchi, Y Ishibashi.   

Abstract

Mitogenic activities for adult skin fibroblasts in 17 sera from untreated patients with scleroderma at the early stage were studied. Mitogenic activities in 10% test sera were measured by the [3H]-thymidine incorporation assay using confluent fibroblasts; there was no significant difference between scleroderma-affected and normal controls. Growth-stimulatory activities for subconfluent fibroblasts in 10% test sera were measured by increased cell numbers; again, there was no significant difference between scleroderma-affected and normal controls. There have been contradictory reports on growth-stimulatory activities in scleroderma sera; our data do not suggest the presence of a specific mitogen in scleroderma sera.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596866     DOI: 10.1007/bf00455321

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitors.

Authors:  E C LeRoy; M B Kahaleh; S Mercurio
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

2.  Cytotoxicity of sera from patients with scleroderma. Effects on human endothelial cells and fibroblasts in culture.

Authors:  S Cohen; A R Johnson; E Hurd
Journal:  Arthritis Rheum       Date:  1983-02

3.  Cytotoxic activity of sera from scleroderma and other connective tissue diseases. Lack of cellular and disease specificity.

Authors:  W R Shanahan; J H Korn
Journal:  Arthritis Rheum       Date:  1982-12

4.  Clinical associations of fibroblast growth promoting factor in scleroderma.

Authors:  S R Potter; J Bienenstock; P Lee; S Wilkinson; W W Buchanan
Journal:  J Rheumatol       Date:  1984-02       Impact factor: 4.666

5.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Dipyridamole decreases platelet-derived growth factor levels in human serum.

Authors:  K Takehara; G R Grotendorst; R Silver; E C LeRoy
Journal:  Arteriosclerosis       Date:  1987 Mar-Apr

7.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

  7 in total
  1 in total

1.  The effects of scleroderma sera on endothelial cell survival in vitro.

Authors:  T Etoh; A Igarashi; K Iozumi; Y Ishibashi; K Takehara
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.